Granulomatosis with Polyangiitis (Wegener Granulomatosis) Presenting as a Pancreatic Mass: A Rare Malignancy Mimic. [PDF]
Sain S +4 more
europepmc +1 more source
Objective The diagnosis of fibromyalgia (FM) is challenging due to the absence of definitive biomarkers, numerous overlapping comorbidities, and its reliance on patient‐reported symptoms. Discrepancies between diagnostic criteria and clinical practice imply the possibility of diagnostic biases, complicating timely and accurate identification.
Sung‐A Kim +2 more
wiley +1 more source
A Flow Cytometry Crossmatch With Combined Cytotoxicity and IgG Detection: Ten Years of Use in Deceased Donor Kidney Allocation. [PDF]
Alheim M, Eich T.
europepmc +1 more source
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin +7 more
wiley +1 more source
Ocular TB as the only manifestation of TB: diagnostic uncertainty and treatment thresholds. [PDF]
Alabed ST, Finkel D.
europepmc +1 more source
Objective The aim of this study was to test the hypothesis that multijoint osteoarthritis would modify the relation between time and frailty progression, in which more affected joints would lead to larger declines over six years compared to those without osteoarthritis using data from the Canadian Longitudinal Study on Aging.
Carson Halliwell +2 more
wiley +1 more source
A Novel Pre-Kidney Transplant Risk Score to Optimize Waiting List Management. [PDF]
Henkel L +9 more
europepmc +1 more source
Shared Mechanistic Pathways in Bullous Pemphigoid, Chronic Spontaneous Urticaria, Prurigo Nodularis, and Chronic Prurigo of Unknown Origin: Implications for Targeted Therapies. [PDF]
Schmidt E, Puga MF, Kim BS, Simpson EL.
europepmc +1 more source
A Blind Spot in Post-Liver Transplant Care: Correlation and Causation in Immunosuppression, Drug Monitoring, and Immune Checkpoint Inhibitor-Related Rejection. [PDF]
Nashan B.
europepmc +1 more source

